5% Off
5% Off
marketed by GALCARE PHARMACEUTICALS PVT LTD
• 20GM
₹148.20
M.R.P.: ₹156
5% Off
Inclusive of all taxes
NAX is a combination of allantoin, clindamycin phosphate and nicotinamide. it is used to control acne, blackheads and whiteheads on the skin. it works by killing the acne-causing bacteria and reduces swelling, redness and pain. this cream's most common side effects are skin peeling, erythema, dry skin, and burning sensation. these side effects can be prevented by using skin moisturizers and av
hypersensitivity pregnancy lactation mother.
babies: consult your doctor because animal and human studies have shown no harmful effects on the developing baby.
lactating mother: safe if prescribed by your doctor because human studies have demonstrated no risk to the baby.
pregnancy: consult your doctor because animal and human studies have shown risk to the developing baby.
driving: no interactions found.
alcohol: no interactions found.
kidney: no interactions found.
liver: no interactions found.
.
Skin peeling Erythema Dry skin Burning sensation.
NAX works by killing the acne-causing bacteria and reduces swelling, redness and pain..
If you miss a dose of NAX cream, apply the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not apply a double amount to make up for a missed one..
• before applying NAX, wash your skin with a mild cleanser and allow to pad dry. • inform your doctor if acne does not get improves within 2-4 weeks of the treatment. • avoid contact with your eyes, nose or mouth. rinse it off with water immediately if you get accidental contact. • drink plenty of water and use moisturizers to avoid dry skin..
contraindicated
• clindamycin phosphate + typhoid vaccine: concurrent use leads to increase in clindamycin phosphate levels by decreasing typhoid vaccine levels.
• clindamycin phosphate + bcg vaccine: concurrent use leads to increase in clindamycin phosphate levels by decreasing bcg vaccine.
serious
• clindamycin phosphate + atracurium: concurrent use leads to increase in atracurium levels by decreasing clindamycin phosphate.
• clindamycin phosphate + pancuronium: concurrent use leads to increase in pancuronium levels by decreasing clindamycin phosphate.
monitor closely
• clindamycin phosphate + digoxin: concurrent use leads to increase in digoxin levels by decreasing clindamycin phosphate.
minor
• clindamycin phosphate + pyridoxine: concurrent use leads to increase in clindamycin phosphate levels by decreasing pyridoxine.
.
100% Authentic
Easy Return